Prevalence of Asymptomatic Bacteriuria and Antibiotic Susceptibility Patterns of Bacterial Isolates among Cancer Patients and Healthy Blood Donors at the University of Gondar Specialized Hospital
Table 3
Antibiotic susceptibility patterns of pathogenic bacterial isolates among cancer patients at the University of Gondar comprehensive specialized hospital, Gondar, Northwest Ethiopia, 2019.
Antibiotics
Cancer patients
E. coli (9)
Klebsiella species (7)
S. aureus (6)
Enterococcus species (3)
Serratia species (2)
E. aerogenes (1)
S (%)
I (%)
R (%)
S (%)
I (%)
R (%)
S (%)
I (%)
R (%)
S (%)
I (%)
R (%)
S (%)
I (%)
R (%)
S (%)
I (%)
R (%)
Ampicillin
11.1
11.1
77.8
14.3
0
85.7
N/A
N/A
N/A
0
0
100
0
0
100
0
0
100
Amoxicillin/clavulanate
44.5
22.2
33.3
57.1
0
42.9
N/A
N/A
N/A
N/A
N/A
N/A
50
0
50
100
0
0
Ceftazidime
100
0
0
57.1
0
42.9
N/A
N/A
N/A
N/A
N/A
N/A
0
0
100
100
0
0
Tobramycin
88.8
0
11.2
57.1
0
42.9
N/A
N/A
N/A
N/A
N/A
N/A
100
0
0
100
0
0
Cefoxitin
100
0
0
71.4
0
28.9
83.3
18.7
0
N/A
N/A
N/A
50
0
50
100
0
0
Vancomycin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
100
0
0
N/A
N/A
N/A
N/A
N/A
N/A
Tetracycline
22.2
0
77.8
42.9
14.2
42.9
33.3
33.3
33.3
33.3
0
66.7
0
0
100
0
0
100
Penicillin
N/A
N/A
N/A
N/A
N/A
N/A
16.7
0
83.3
0
0
100
N/A
N/A
N/A
N/A
N/A
N/A
Ciprofloxacin
77.8
0
22.2
71.4
0
28.9
66.6
16.7
16.7
66.7
0
33.3
50
0
50
100
0
0
Norfloxacin
77.8
0
22.2
71.4
0
28.9
83.3
0
18.7
0
33.3
66.7
50
0
50
100
0
0
Nitrofurantoin
77.8
0
22.2
85.7
0
14.3
100
0
0
100
0
0
100
0
0
100
0
0
Nalidixic acid
100
0
0
85.7
0
14.3
N/A
N/A
N/A
N/A
N/A
N/A
0
0
100
100
0
0
Rifampicin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
33.3
0
66.7
N/A
N/A
N/A
N/A
N/A
N/A
S = susceptible; I = intermediate; R = resistance; N/A = not applicable.
